FR3692M - Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. - Google Patents
Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique.Info
- Publication number
- FR3692M FR3692M FR988116A FR988116A FR3692M FR 3692 M FR3692 M FR 3692M FR 988116 A FR988116 A FR 988116A FR 988116 A FR988116 A FR 988116A FR 3692 M FR3692 M FR 3692M
- Authority
- FR
- France
- Prior art keywords
- hypnotic
- therapy
- amino acid
- new amino
- spasmolytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001413 amino acids Chemical class 0.000 title 1
- 239000000812 cholinergic antagonist Substances 0.000 title 1
- 230000000147 hypnotic effect Effects 0.000 title 1
- 230000003387 muscular Effects 0.000 title 1
- 230000002048 spasmolytic effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR988116A FR3692M (fr) | 1963-07-09 | 1964-09-15 | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH853763A CH446376A (de) | 1963-07-09 | 1963-07-09 | Verfahren zur Herstellung neuer Aminosäuren |
CH672964 | 1964-05-22 | ||
FR980779A FR1431697A (fr) | 1963-07-09 | 1964-07-06 | Procédé de préparation de nouveaux acides aminés, entre autres l'acide gamma-amino-beta-(p-chlorophényl)butyrique |
FR988116A FR3692M (fr) | 1963-07-09 | 1964-09-15 | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. |
Publications (1)
Publication Number | Publication Date |
---|---|
FR3692M true FR3692M (fr) | 1965-11-15 |
Family
ID=25700075
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR988115A Active FR3677M (fr) | 1963-07-09 | 1964-09-15 | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire, anticonvulsivant, hypnotique ou sédatif. |
FR988116A Active FR3692M (fr) | 1963-07-09 | 1964-09-15 | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR988115A Active FR3677M (fr) | 1963-07-09 | 1964-09-15 | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire, anticonvulsivant, hypnotique ou sédatif. |
Country Status (9)
Country | Link |
---|---|
US (1) | US3471548A (fr) |
BE (1) | BE650258A (fr) |
BR (1) | BR6460727D0 (fr) |
CH (1) | CH449645A (fr) |
DE (1) | DE1493536B1 (fr) |
ES (1) | ES301814A1 (fr) |
FR (2) | FR3677M (fr) |
GB (1) | GB1017439A (fr) |
SE (4) | SE333151B (fr) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3956314A (en) * | 1970-07-24 | 1976-05-11 | U.C.B., Societe Anonyme | Derivatives of 2-pyrrolidinone |
US3947579A (en) * | 1974-06-03 | 1976-03-30 | Nelson Research & Development Company | Method and composition for potentiating neuroleptic drugs |
US3978216A (en) * | 1974-06-03 | 1976-08-31 | Nelson Research & Development Company | Method for treating schizophrenia and method and composition for potentiating neuroleptic drugs |
US4084000A (en) * | 1975-07-16 | 1978-04-11 | Nelson Research And Development Company | Method of treating schizophrenia |
US4126684A (en) * | 1976-02-11 | 1978-11-21 | Ciba-Geigy Corporation | 4-amino-3-p-halophenylbutyric acids and their derivatives used in the control of narcotic abuse |
NL7706429A (nl) * | 1977-06-10 | 1978-12-12 | Univ Erasmus | Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking. |
NL8006135A (nl) * | 1980-11-10 | 1982-06-01 | Univ Erasmus | Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel. |
US5006560A (en) * | 1989-12-20 | 1991-04-09 | Schering Corporation | Use of GABA-B selective agonists as anti-tussive agents |
CA2240937C (fr) * | 1995-12-20 | 2004-06-01 | Farmarc Nederland B.V. | Procede de resolution optique de 3-(p-chlorophenyl)-glutaramide |
WO1998003167A1 (fr) | 1996-07-24 | 1998-01-29 | Warner-Lambert Company | Isobutylgaba et ses derives utilises pour le traitement de la douleur |
WO2002043762A2 (fr) | 2000-11-30 | 2002-06-06 | Pfizer Products Inc. | Combinaison d'agonistes gaba et d'inhibiteurs de la sorbitol-deshydrogenase (sdi) |
MXPA03004871A (es) | 2000-11-30 | 2003-08-19 | Pfizer Prod Inc | Combinacion de agonistas de gaba e inhibidores de aldosa-reductasa. |
CA2525366A1 (fr) * | 2003-05-16 | 2004-11-25 | Pfizer Products Inc. | Combinaisons therapeutiques d'antipsychotiques atypiques avec des modulateurs de l'acide 4-aminobutanoique et/ou des medicaments anticonvulsivants |
EP2354120A1 (fr) | 2003-08-20 | 2011-08-10 | XenoPort, Inc. | Synthèse de promédicaments a base de carbamate d'acyloxyalkyle et leurs intermédiaires |
KR101140559B1 (ko) * | 2003-08-20 | 2012-07-05 | 제노포트 인코포레이티드 | 아실옥시알킬 카르바메이트 프로드러그, 합성 및 사용 방법 |
PL1691811T3 (pl) | 2003-12-11 | 2014-12-31 | Sunovion Pharmaceuticals Inc | Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji |
EP1737466A1 (fr) * | 2004-01-29 | 2007-01-03 | Pfizer Products Inc. | COMBINAISON DE MODULATEURS D'ACIDE GAMMA-AMINOBUTYRIQUE ET D'ANTAGONISTES DU RECEPTEUR 5-HT-1b |
EP2258358A3 (fr) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenèse avec un inhibiteur de l'acetylcholinestérase |
EP2275095A3 (fr) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese par modulation des recepteurs muscariniques |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (fr) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Modulation de la neurogenese dont la mediation est assuree par recepteur gaba |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5ht受容体介在性の神経新生 |
EP2058008B1 (fr) | 2006-08-11 | 2013-08-21 | National University Corporation Nagoya University | Agent anti-obésité et son utilisation |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CN101631768A (zh) * | 2007-03-15 | 2010-01-20 | 太阳医药高级研究有限公司 | 新型前药 |
WO2010099217A1 (fr) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine |
WO2011113904A1 (fr) | 2010-03-17 | 2011-09-22 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Médicaments pour la prévention et le traitement d'une maladie associée à la dégénérescence des cellules ganglionnaires rétiniennes |
US20180208544A1 (en) | 2015-07-13 | 2018-07-26 | Piramal Enterprises Limited | An improved process for the preparation of baclofen and its intermediate |
CN106187794A (zh) * | 2016-07-12 | 2016-12-07 | 安徽省逸欣铭医药科技有限公司 | 一种巴氯芬的绿色工业化生产方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3125583A (en) * | 1964-03-17 | Hjnc oxchaxohxchc o oh |
-
1963
- 1963-07-09 CH CH1468666A patent/CH449645A/de unknown
-
1964
- 1964-06-24 GB GB26174/64A patent/GB1017439A/en not_active Expired
- 1964-06-30 US US379365A patent/US3471548A/en not_active Expired - Lifetime
- 1964-07-03 DE DE19641493536 patent/DE1493536B1/de active Pending
- 1964-07-08 BR BR160727/64A patent/BR6460727D0/pt unknown
- 1964-07-08 SE SE8340/64A patent/SE333151B/xx unknown
- 1964-07-08 SE SE08945/67A patent/SE348462B/xx unknown
- 1964-07-08 ES ES0301814A patent/ES301814A1/es not_active Expired
- 1964-07-08 SE SE08944/67A patent/SE348461B/xx unknown
- 1964-07-08 BE BE650258A patent/BE650258A/xx unknown
- 1964-07-08 SE SE08943/67A patent/SE348460B/xx unknown
- 1964-09-15 FR FR988115A patent/FR3677M/fr active Active
- 1964-09-15 FR FR988116A patent/FR3692M/fr active Active
Also Published As
Publication number | Publication date |
---|---|
BE650258A (fr) | 1965-01-08 |
GB1017439A (en) | 1966-01-19 |
SE348462B (fr) | 1972-09-04 |
CH449645A (de) | 1968-01-15 |
DE1493536B1 (de) | 1971-10-14 |
US3471548A (en) | 1969-10-07 |
SE333151B (sv) | 1971-03-08 |
BR6460727D0 (pt) | 1973-08-02 |
SE348461B (fr) | 1972-09-04 |
FR3677M (fr) | 1965-11-08 |
ES301814A1 (es) | 1965-01-01 |
SE348460B (fr) | 1972-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3692M (fr) | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. | |
FR3290M (fr) | Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase. | |
FR302M (fr) | Nouvelle m-butoxy-phénoxy-éthylamine utilisable en thérapeutique. | |
FR3439M (fr) | Nouvelle quinazoline utilisable en thérapeutique, notamment comme analgésique. | |
FR3818M (fr) | Nouvel imidazole utilisable en thérapeutique, notamment comme agent antischistosomien et antiamibien. | |
FR3416M (fr) | Nouveau aminoacide utilisable en thérapeutique, notamment comme spasmolytique musculaire et hypnotique. | |
FR3734M (fr) | Nouvelle pipérazine utilisable en thérapeutique, notamment comme agent hypotenseur. | |
FR3534M (fr) | Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme agent antitussif. | |
IL31021A0 (en) | New n,n-dialkyl benzamides and their use as herbicides | |
FR2691M (fr) | Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme gestagenes. | |
FR3309M (fr) | Nouvelle pipérazine utilisable en thérapeutique, notamment comme antiphlogistique. | |
FR3006M (fr) | Nouveau médicament utilisable notamment comme analgésique, antipyrétique et antirhumatismal. | |
FR1898M (fr) | Nouvelle substance utilisable en thérapeutique. | |
FR270M (fr) | Nouvelles urées utilisables en thérapeutique. | |
OA00736A (fr) | N-hydroxyméthyl-benzamides et thibenzamides chlorés utilisables notamment comme herbicides. | |
FR1733M (fr) | Nouvelle urée utilisable en thérapeutique, notamment comme hypoglycémiant. | |
FR2955M (fr) | Médicament utilisable notamment comme analgésique et hypnotique a base de 4-alcoylamidophénylcarbonates d'haloalcoyle. | |
FR2998M (fr) | Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants. | |
FR1013M (fr) | Médicament analgésique, antithermique et antirhumatismal. | |
FR347M (fr) | Nouvelle 1,3-dihydroxy-2-amino-nonadec-4-yne utilisable en thérapeutique. | |
FR353M (fr) | Nouvelle quinoléine utilisable en thérapeutique. | |
FR2999M (fr) | Nouvelle guanidine utilisable en thérapeutique, notamment comme hypoglycémiant. | |
FR3864M (fr) | Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs. | |
FR2714M (fr) | Nouveau sulfonamide utilisable en thérapeutique, notamment comme agent chimiothérapique. | |
FR2745M (fr) | Nouveau sulfonamide utilisable en thérapeutique, notamment comme agent chimiothérapique. |